Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of ABSK-011 in patients with advanced liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ABSK-011

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Advanced Liver Cancer | Phase 1 | Status: RECRUITING